Ascribe PLC - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Ascribe PLC Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Ascribe PLC. The Group's principal activity is developing, supplying and supporting software solutions. The Group's operation focuses on providing software solutions supporting patient, clinical and business processes to the international healthcare market. The Group's operation relates to hospital and pharmacy systems, emergency department, retail pharmacy, mental health, primary and social care. The Group's software products ensures that the drug prescribed will not react with any patient allergies, with any medicine the patient is already taking, and furthermore checks that the drug dose is correct for the patient's height, weight and other related information. Product brands include Ascribe, E-MAT, ePEX, Exeter, Park ETP and Symphony. The Group operates predominantly in the United Kingdom.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report